Grant: Project Grant
Research Institute of the McGill University Health Centre
$749,700.00
Defining the role of fetal reprogramming in the gut epithelium in health and disease.
FY 2022-23
Summary
During embryonic development, pluripotent stem cells play a fundamental role in creating the wide variety of tissue types in our bodies. More specialised stem cells are also critical in ensuring that tissues maintain an ability to repair themselves following injury throughout life. One of the fundamental properties of stem cells that has been revealed over the last decade is their ability to acquire new characteristics and adapt to the surrounding microenvironment. This process is known as cellular plasticity and implies that the stem cell state is not fixed in time. In fact, we now know that virtually all cells may acquire stem cell attributes if exposed to the appropriate cues. Our research team has developed unique expertise in unraveling the signals that govern stem cell plasticity in the developing and regenerating intestinal epithelium, one of the most highly proliferative tissues known in the human body. Our data suggests that epithelial cells in the gut transition from an adult to a fetal state in response to a wide range of environmental triggers. With this knowledge, we aim to study the molecular mechanisms regulating fetal progenitor cells during gut morphogenesis and their relation to regenerative stem cells activated following intestinal injury. Finally, we will investigate the role of fetal-like stem cells during colorectal cancer progression. To pursue these aims we will exploit genetically modified mouse models as well as patient-derived tumor cell cultures. We anticipate that this proposal may lead to novel strategies that promote tissue regeneration in the context of inflammatory bowel disease, as well as identify vulnerabilities of colorectal cancer cells that can be targeted therapeutically.
Department
Program
Project Grant
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
469443
Name
Gregorieff Alex
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Cell Biology - Disease
Projecttitle
Defining the role of fetal reprogramming in the gut epithelium in health and disease.
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$749,700
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Colorectal Cancer; Conditional Ko Mice; Fetal Gut Development; Fetal Reprogramming; Hippo Signaling; Intestinal Regeneration; Intestinal Stem Cell; Organoids; Tgf-Beta Signaling; Wnt Signaling
Abstract
During embryonic development, pluripotent stem cells play a fundamental role in creating the wide variety of tissue types in our bodies. More specialised stem cells are also critical in ensuring that tissues maintain an ability to repair themselves following injury throughout life. One of the fundamental properties of stem cells that has been revealed over the last decade is their ability to acquire new characteristics and adapt to the surrounding microenvironment. This process is known as cellular plasticity and implies that the stem cell state is not fixed in time. In fact, we now know that virtually all cells may acquire stem cell attributes if exposed to the appropriate cues. Our research team has developed unique expertise in unraveling the signals that govern stem cell plasticity in the developing and regenerating intestinal epithelium, one of the most highly proliferative tissues known in the human body. Our data suggests that epithelial cells in the gut transition from an adult to a fetal state in response to a wide range of environmental triggers. With this knowledge, we aim to study the molecular mechanisms regulating fetal progenitor cells during gut morphogenesis and their relation to regenerative stem cells activated following intestinal injury. Finally, we will investigate the role of fetal-like stem cells during colorectal cancer progression. To pursue these aims we will exploit genetically modified mouse models as well as patient-derived tumor cell cultures. We anticipate that this proposal may lead to novel strategies that promote tissue regeneration in the context of inflammatory bowel disease, as well as identify vulnerabilities of colorectal cancer cells that can be targeted therapeutically.
Competitiondate
202209
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Gregorieff, Alex
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $749,700~ $0~